4:08 PM
 | 
Feb 12, 2018
 |  BC Extra  |  Financial News

DiaCarta closes $45M series B

Molecular diagnostics company DiaCarta Inc. (Hayward, Calif.) said it completed a $45 million series...

Read the full 46 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >